Alnylam Pharmaceuticals, Inc.
ALNY Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
ALNY Income Statement
ALNY Balance Sheet
ALNY Cash Flow
Recent trades of ALNY by members of U.S. Congress
ALNY Stock Insider Trading Activity
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
ALNY Stock Institutional Owners
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
ALNY Derivatives Institutional Owners
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by ALNY's directors and management
Government lobbying spending instances
-
$480,000 Oct 21, 2024 Issue: Veterans Medicare/Medicaid
-
$480,000 Jul 22, 2024 Issue: Veterans Medicare/Medicaid
-
$290,000 Apr 22, 2024 Issue: Medicare/Medicaid
-
$220,000 Jan 22, 2024 Issue: Medicare/Medicaid
-
$220,000 Oct 20, 2023 Issue: Medicare/Medicaid
-
$50,000 Jul 20, 2023 Issue: Medicare/Medicaid
-
$50,000 Jul 20, 2023 Issue: Health Issues Medicare/Medicaid
-
$50,000 Jul 20, 2023 Issue: Medicare/Medicaid
-
$60,000 Jul 14, 2023 Issue: Medicare/Medicaid
-
$50,000 Jan 20, 2023 Issue: Medicare/Medicaid
-
$50,000 Jan 20, 2023 Issue: Health Issues Medicare/Medicaid
-
$50,000 Jan 20, 2023 Issue: Medicare/Medicaid
-
$100,000 Jan 14, 2023 Issue: Medicare/Medicaid
-
$50,000 Oct 20, 2022 Issue: Medicare/Medicaid
-
$50,000 Oct 20, 2022 Issue: Medicare/Medicaid
-
$60,000 Oct 20, 2022 Issue: Health Issues Medicare/Medicaid
-
$60,000 Oct 16, 2022 Issue: None
-
$50,000 Jul 20, 2022 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid
-
$50,000 Jul 20, 2022 Issue: Medicare/Medicaid
-
$50,000 Jul 20, 2022 Issue: Health Issues Medicare/Medicaid
-
$60,000 Jul 15, 2022 Issue: None
-
$40,000 Jul 15, 2022 Issue: Medicare/Medicaid
-
$60,000 Apr 20, 2022 Issue: Medicare/Medicaid
-
$50,000 Apr 20, 2022 Issue: Medicare/Medicaid
-
$50,000 Apr 19, 2022 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid
-
$40,000 Apr 15, 2022 Issue: None
-
$40,000 Apr 14, 2022 Issue: Medicare/Medicaid
-
$50,000 Jan 20, 2022 Issue: Medicare/Medicaid
-
$60,000 Jan 20, 2022 Issue: Medicare/Medicaid
-
$50,000 Jan 19, 2022 Issue: Medicare/Medicaid
-
$40,000 Jan 13, 2022 Issue: Medicare/Medicaid
-
$50,000 Oct 20, 2021 Issue: Medicare/Medicaid
-
$50,000 Oct 20, 2021 Issue: Medicare/Medicaid
-
$50,000 Oct 15, 2021 Issue: Medicare/Medicaid Health Issues
-
$40,000 Oct 14, 2021 Issue: Medicare/Medicaid
-
$30,000 Jul 20, 2021 Issue: Medicare/Medicaid Health Issues
-
$50,000 Jul 20, 2021 Issue: Medicare/Medicaid
-
$50,000 Jul 20, 2021 Issue: Medicare/Medicaid
-
$40,000 Jul 13, 2021 Issue: Medicare/Medicaid
-
$50,000 Apr 20, 2021 Issue: Medicare/Medicaid
-
$60,000 Apr 20, 2021 Issue: Medicare/Medicaid
-
$30,000 Apr 13, 2021 Issue: Health Issues Medicare/Medicaid
-
$40,000 Apr 12, 2021 Issue: Medicare/Medicaid
-
$30,000 Jan 20, 2021 Issue: Health Issues Medicare/Medicaid
-
$30,000 Jan 20, 2021 Issue: Medicare/Medicaid
-
$50,000 Jan 20, 2021 Issue: Medicare/Medicaid
-
$50,000 Jan 19, 2021 Issue: Medicare/Medicaid
-
$50,000 Oct 20, 2020 Issue: Medicare/Medicaid
-
$30,000 Oct 16, 2020 Issue: Medicare/Medicaid
-
$50,000 Oct 14, 2020 Issue: Medicare/Medicaid
-
$30,000 Oct 06, 2020 Issue: Health Issues Medicare/Medicaid
-
$50,000 Jul 20, 2020 Issue: Medicare/Medicaid Taxation/Internal Revenue Code
-
$30,000 Jul 15, 2020 Issue: Medicare/Medicaid
-
$50,000 Jul 15, 2020 Issue: Medicare/Medicaid
-
$30,000 Jul 14, 2020 Issue: Health Issues Medicare/Medicaid
-
$30,000 Apr 20, 2020 Issue: Medicare/Medicaid
-
$50,000 Apr 19, 2020 Issue: Medicare/Medicaid
-
$30,000 Apr 17, 2020 Issue: Health Issues Medicare/Medicaid
-
$50,000 Apr 17, 2020 Issue: Medicare/Medicaid
-
$30,000 Jan 21, 2020 Issue: Medicare/Medicaid
-
$50,000 Jan 21, 2020 Issue: Medicare/Medicaid
-
$60,000 Jan 17, 2020 Issue: Medicare/Medicaid
-
$30,000 Oct 21, 2019 Issue: Medicare/Medicaid
-
$50,000 Oct 21, 2019 Issue: Medicare/Medicaid
-
$40,000 Oct 21, 2019 Issue: Medicare/Medicaid
-
$20,000 Oct 21, 2019 Issue: Health Issues
-
$30,000 Jul 22, 2019 Issue: Medicare/Medicaid
-
$30,000 Jul 22, 2019 Issue: Health Issues
-
$50,000 Jul 22, 2019 Issue: Medicare/Medicaid
-
$50,000 Jul 16, 2019 Issue: Medicare/Medicaid
-
$30,000 Apr 22, 2019 Issue: Medicare/Medicaid
-
$50,000 Apr 22, 2019 Issue: Medicare/Medicaid
-
$40,000 Apr 22, 2019 Issue: Medicare/Medicaid
-
$40,000 Apr 22, 2019 Issue: Health Issues
-
$30,000 Jan 22, 2019 Issue: Medicare/Medicaid
-
$40,000 Jan 22, 2019 Issue: Health Issues
-
$30,000 Jan 22, 2019 Issue: Medicare/Medicaid
-
$30,000 Jan 21, 2019 Issue: Health Issues
-
$40,000 Oct 22, 2018 Issue: Health Issues
-
$30,000 Oct 22, 2018 Issue: Medicare/Medicaid
-
$30,000 Oct 22, 2018 Issue: Health Issues
-
$30,000 Oct 19, 2018 Issue: Medicare/Medicaid
-
$40,000 Jul 20, 2018 Issue: Health Issues
-
$30,000 Jul 19, 2018 Issue: Health Issues
-
$40,000 Apr 20, 2018 Issue: Health Issues
-
$30,000 Apr 20, 2018 Issue: Health Issues
-
$20,000 Jan 22, 2018 Issue: Health Issues
-
$40,000 Jan 22, 2018 Issue: Health Issues
-
$40,000 Oct 20, 2017 Issue: Health Issues
-
$40,000 Jul 20, 2017 Issue: Health Issues
-
$30,000 Jul 20, 2017 Issue: Medicare/Medicaid Health Issues
-
$30,000 Apr 20, 2017 Issue: Medicare/Medicaid Health Issues
-
$40,000 Apr 20, 2017 Issue: Health Issues
-
$40,000 Jan 23, 2017 Issue: Health Issues
-
$30,000 Jan 19, 2017 Issue: Medicare/Medicaid Health Issues
-
$40,000 Oct 26, 2016 Issue: Health Issues
-
$30,000 Oct 20, 2016 Issue: Medicare/Medicaid Health Issues
-
$30,000 Jul 20, 2016 Issue: Medicare/Medicaid Health Issues
-
$30,000 Apr 20, 2016 Issue: Health Issues Medicare/Medicaid
-
$50,000 Jan 20, 2016 Issue: Health Issues Medicare/Medicaid
Estimated quarterly lobbying spending
U.S. Patents
New patents grants
-
Patent Title: Xanthine dehydrogenase (xdh) irna compositions and methods of use thereof Sep. 17, 2024
-
Patent Title: Serpina1 irna compositions and methods of use thereof Aug. 27, 2024
-
Patent Title: Carbohydrate conjugates as delivery agents for oligonucleotides Aug. 13, 2024
-
Patent Title: Factor xii (f12) irna compositions and methods of use thereof Jul. 30, 2024
-
Patent Title: Transthyretin (ttr) irna compositions and methods of use thereof for treating or preventing ttr-associated diseases Jul. 30, 2024
-
Patent Title: Gnaq targeted dsrna compositions and methods for inhibiting expression Jul. 09, 2024
-
Patent Title: Tunable reversir™ compounds Jun. 25, 2024
-
Patent Title: Extrahepatic delivery Jun. 11, 2024
-
Patent Title: Huntingtin (htt) irna agent compositions and methods of use thereof May. 28, 2024
-
Patent Title: Compositions and methods for inhibiting expression of the lect2 gene May. 21, 2024
-
Patent Title: Complement factor b (cfb) irna compositions and methods of use thereof Apr. 23, 2024
-
Patent Title: Transthyretin (ttr) irna compositions and methods of use thereof Apr. 16, 2024
-
Patent Title: Carbohydrate conjugate rna agents and process for their preparation Apr. 02, 2024
-
Patent Title: Ketohexokinase (khk) irna compositions and methods of use thereof Mar. 12, 2024
-
Patent Title: Lipid formulated compositions and methods for inhibiting expression of serum amyloid a gene Jan. 30, 2024
-
Patent Title: Complement component c5 irna compositions and methods of use thereof Jan. 16, 2024
-
Patent Title: Transmembrane protease, serine 6 (tmprss6) irna compositions and methods of use thereof Jan. 09, 2024
-
Patent Title: Angiopoietin-like 3 (angptl3) irna compositions and methods of use thereof Jan. 09, 2024
-
Patent Title: Complement component c3 irna compositions and methods of use thereof Jan. 09, 2024
-
Patent Title: Glucokinase (gck) irna compositions and methods of use thereof Jan. 02, 2024
-
Patent Title: Angiopoietin-like 3 (angptl3) irna compositions and methods of use thereof Dec. 12, 2023
-
Patent Title: Angiopoietin-like 3 (angptl3) irna compositions and methods of use thereof Dec. 05, 2023
-
Patent Title: Angiotensinogen (agt) irna compositions and methods of use thereof Dec. 05, 2023
-
Patent Title: Dosages and methods for delivering lipid formulated nucleic acid molecules Nov. 28, 2023
-
Patent Title: Compositions and methods for treating transthyretin (ttr) mediated amyloidosis Nov. 07, 2023
-
Patent Title: Tmprss6 irna compositions and methods of use thereof Aug. 15, 2023
-
Patent Title: Serpina1 irna compositions and methods of use thereof Aug. 15, 2023
-
Patent Title: Programmed cell death 1 ligand 1 (pd-l1) irna compositions and methods of use thereof Jun. 27, 2023
-
Patent Title: Biodegradable lipids for the delivery of active agents Jun. 20, 2023
-
Patent Title: Carbohydrate conjugates as delivery agents for oligonucleotides Jun. 06, 2023
-
Patent Title: Superoxide dismutase 1 (sod1) irna compositions and methods of use thereof for treating or preventing superoxide dismutase 1-(sod1-) associated neurodegenerative diseases May. 16, 2023
-
Patent Title: Biodegradable lipids for the delivery of active agents Apr. 25, 2023
-
Patent Title: Biodegradable lipids for the delivery of active agents Apr. 25, 2023
-
Patent Title: Angiopoietin-like 3 (angptl3) irna compositions and methods of use thereof Mar. 28, 2023
-
Patent Title: Biodegradable lipids for the delivery of active agents Mar. 28, 2023
-
Patent Title: Chirally-enriched double-stranded rna agents Mar. 07, 2023
-
Patent Title: Biodegradable lipids for the delivery of active agents Feb. 28, 2023
-
Patent Title: Modified double-stranded rna agents Jan. 10, 2023
-
Patent Title: Therapeutic compositions Dec. 20, 2022
-
Patent Title: Angiopoietin-like 3 (angptl3) irna compositions and methods of use thereof Dec. 13, 2022
-
Patent Title: Modified rna agents with reduced off-target effect Nov. 22, 2022
-
Patent Title: Hepatitis b virus (hbv) dsrna agent compositions and methods of use thereof Nov. 08, 2022
-
Patent Title: Compositions and methods for inhibition of hao1 (hydroxyacid oxidase 1 (glycolate oxidase)) gene expression Sep. 20, 2022
-
Patent Title: Sterol regulatory element binding protein (srebp) chaperone (scap) irna compositions and methods of use thereof Sep. 06, 2022
-
Patent Title: Modified double-stranded rna agents Aug. 30, 2022
-
Patent Title: Angiotensinogen (agt) irna compositions and methods of use thereof Aug. 23, 2022
-
Patent Title: Apolipoprotein c3 (apoc3) irna compositions and methods of use thereof Aug. 09, 2022
-
Patent Title: Modified rnai agents Aug. 09, 2022
-
Patent Title: Modified double-stranded rna agents Aug. 02, 2022
-
Patent Title: Biodegradable lipids for the delivery of active agents Aug. 02, 2022
Government Contracts
Federal grants, loans, and purchases
Government Contracts
Estimated quarterly amount awarded from public contracts
WallStreetBets
Number of mentions of ALNY in WallStreetBets Daily Discussion
ALNY News
Recent insights relating to ALNY
CNBC Recommendations
Recent picks made for ALNY stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in ALNY
ALNY Top Shareholders
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
ALNY Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view ALNY Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More